产品名称 | NebuSelect™ Recombinant Human-AREG, hFc-tag |
---|---|
目录号 | NBL-241058 |
别名 | AREG; Amphiregulin; AR; SDGF; AREG; AREGB; CRDGF; MGC13647 |
外观 | see COA |
分子量 | Ser101-Lys187 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P15514 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-241058-100ug | 100ug | Inquire | Inquire | |
NBL-241058-1mg | 1mg | Inquire | Inquire | |
NBL-241058-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human-AREG, hFc-tag
Catalog#:
NBL-241058
Description:
NebuSelect™ Recombinant Human-AREG, hFc-tag(Cat#NBL-241058) is expressed in HEK293 with hFc tag at the N-terminus.It contains Ser101-Lys187.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 37.3 kDa. Due to glycosylation, the protein migrates to 45-50 kDa based on Bis-Tris PAGE result.
Target Name:
AREG; Amphiregulin; AR; SDGF; AREG; AREGB; CRDGF; MGC13647
Target Information:
Amphiregulin (AREG) is a member of the epidermal growth factor (EGF) family and is expressed in a plethora of cancers. Tumour growth and metastasis were decreased by AREG silencing in an orthotopic model of pancreatic cancer. AREG may play a critical role in cell migration, invasion, and EMT by activating the EGFR/ERK/NF‑κB signalling pathway in pancreatic cancer cells.
Amino Acid Sequence:
Ser101-Lys187
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.